Twin Brook Capital Partners (Twin Brook), the middle-market direct lending subsidiary of Angelo Gordon, has committed over USD2 billion to private equity sponsors in support of healthcare sector transactions in the middle market, including over USD1 billion last year alone.
In 2018, Twin Brook closed on 30 healthcare transactions, bringing the Firm’s total number of healthcare transactions to more than 80 since inception.
“We are pleased to build upon our success and expertise in healthcare by deploying over USD1 billion to transactions in the sector in 2018. Last year’s landmark lending illustrates our ongoing commitment to supporting our private equity sponsor clients investing in US middle-market healthcare companies,” says Faraaz Kamran, a Twin Brook Partner focussed on the Firm’s Healthcare Lending business. “We are seeing an increased appetite for this sector by our private equity sponsor clients, and look forward to putting more capital to work in support of their transactions in 2019, and for years to come.”
In 2018, Twin Brook served as Lead Agent on nearly all healthcare transactions it supported, which included 15 new platform financings and 14 add-on financings.
Twin Brook focuses on loans to private equity-owned companies with EBITDA between USD3 million and USD50 million, with an emphasis on companies with USD25 million of EBITDA and below. The Firm targets senior financing opportunities up to USD400 million with hold sizes across the Twin Brook platform ranging from USD25 million up to USD150 million. Since inception in the fourth quarter of 2014, Twin Brook has closed 291 transactions and provided total arranged commitments of approximately USD9 billion.
